Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Hadaegh, Farzad ^a   Bozorgmanesh, Mohammadreza ^a   Safarkhani, Maryam ^a   Khalili, Davood ^a   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

body mass index; diabetes; metabolic syndrome; prediction

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; FORECASTING; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK; STATISTICAL MODEL;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; FORECASTING; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; YOUNG ADULT;

EID: 80054856237     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-383     Document Type: Article

References (41)

1. Diabetes - a common, growing, serious, costly, and potentially preventable public health problem. KM Narayan EW Gregg A Fagot-Campagna MM Engelgau F Vinicor, Diabetes Res Clin Pract 2000 50 Suppl 2 77 84 11024588
2. Metabolic syndrome and incident diabetes: current state of the evidence. ES Ford C Li N Sattar, Diabetes Care 2008 31 1898 1904 10.2337/dc08-0423 18591398
3. Searching for genes underlying normal variation in human adiposity. AG Comuzzie JT Williams LJ Martin J Blangero, J Mol Med 2001 79 57 70 10.1007/s001090100202 11327104 (Pubitemid 32250023)
4. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. E Succurro MA Marini S Frontoni ML Hribal F Andreozzi R Lauro F Perticone G Sesti, Obesity (Silver Spring) 2008 16 1881 1886 10.1038/oby.2008.308
5. Metabolic Syndrome in Normal-Weight Americans. M-P St-Onge I Janssen SB Heymsfield, Diabetes Care 2004 27 2222 2228 10.2337/diacare.27.9.2222 15333488
6. The metabolically obese, normal-weight individual revisited. N Ruderman D Chisholm X Pi-Sunyer S Schneider, Diabetes 1998 47 699 713 10.2337/diabetes.47. 5.699 9588440 (Pubitemid 28201798)
7. The "metabolically-obese," normal-weight individual. NB Ruderman SH Schneider P Berchtold, Am J Clin Nutr 1981 34 1617 1621 7270486
8. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. RV Dvorak WF DeNino PA Ades ET Poehlman, Diabetes 1999 48 2210 2214 10.2337/diabetes.48.11.2210 10535456 (Pubitemid 29521852)
9. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. A Romero-Corral VK Somers J Sierra-Johnson Y Korenfeld S Boarin J Korinek MD Jensen G Parati F Lopez-Jimenez, European Heart Journal 31 737 746
10. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease. JB Meigs PWF Wilson CS Fox RS Vasan DM Nathan LM Sullivan RB D'Agostino, J Clin Endocrinol Metab 2006 91 2906 2912 10.1210/jc.2006-0594 16735483 (Pubitemid 44271734)
11. Are there persons who are obese, but metabolically healthy? EA Sims, Metabolism 2001 50 1499 1504 10.1053/meta.2001.27213 11735101 (Pubitemid 34007425)
12. What Are the Physical Characteristics Associated with a Normal Metabolic Profile Despite a High Level of Obesity in Postmenopausal Women? M Brochu A Tchernof IJ Dionne CK Sites GH Eltabbakh EAH Sims ET Poehlman, J Clin Endocrinol Metab 2001 86 1020 1025 10.1210/jc.86.3.1020 11238480 (Pubitemid 32322976)
13. The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile. AD Karelis M Faraj J-P Bastard DH St-Pierre M Brochu D Prud'homme R Rabasa-Lhoret, J Clin Endocrinol Metab 2005 90 4145 4150 10.1210/jc.2005-0482 15855252 (Pubitemid 41058189)
14. Can we identify metabolically healthy but obese individuals (MHO)? AD Karelis M Brochu R Rabasa-Lhoret, Diabetes Metab 2004 30 569 572 10.1016/S1262-3636(07)70156-8 15671927 (Pubitemid 40070359)
15. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). RP Wildman P Muntner K Reynolds AP McGinn S Rajpathak J Wylie-Rosett MR Sowers, Arch Intern Med 2008 168 1617 1624 10.1001/archinte.168.15.1617 18695075
16. Metabolic syndrome in normal-weight Iranian adults. F Hadaegh A Zabetian H Harati F Azizi, Ann Saudi Med 2007 27 18 24 10.4103/0256-4947.51537 17277499 (Pubitemid 46584411)
17. Metabolic risks in individuals with normal body mass index and normal waist circumference. F Hadaegh A Esmaillzadeh F Azizi, Eur J Cardiovasc Prev Rehabil 2007 14 200 207 10.1097/01.hjr.0000230096.73579.64 17446797 (Pubitemid 46650074)
18. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. K Lee, Asia Pac J Clin Nutr 2009 18 280 284 19713189
19. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. JB Meigs PW Wilson CS Fox RS Vasan DM Nathan LM Sullivan RB D'Agostino, J Clin Endocrinol Metab 2006 91 2906 2912 10.1210/jc.2006-0594 16735483 (Pubitemid 44271734)
20. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. J Arnlov E Ingelsson J Sundstrom L Lind, Circulation 2010 121 230 236 10.1161/CIRCULATIONAHA.109.887521 20038741
21. Reduction in Incidence of Type 2 Diabetes by Lifestyle Intervention in a Middle Eastern Community. H Harati F Hadaegh AA Momenan L Ghanei M Bozorgmanesh A Ghanbarian P Mirmiran F Azizi, Am J of Prev Med 2010
22. Type 2 Diabetes Prevention: A Review. LA Ahmad JP Crandall, Clinical Diabetes 2010 28 53 59 10.2337/diaclin.28.2.53
23. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. F Azizi A Ghanbarian AA Momenan F Hadaegh P Mirmiran M Hedayati Y Mehrabi S Zahedi-Asl, Trials 2009 10 5 19166627
24. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). F Azizi M Rahmani H Emami P Mirmiran R Hajipour M Madjid J Ghanbili A Ghanbarian Y Mehrabi N Saadat, et al. Soz Praventivmed 2002 47 408 426 12643001 (Pubitemid 36285040)
25. Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood Institute. SM Grundy, Arterioscler Thromb Vasc Biol 2005 25 2243 2244 10.1161/01.ATV.0000189155.75833.c7 16258150 (Pubitemid 41552637)
26. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato JC Fruchart WP James CM Loria SC Smith Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
27. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. F Hadaegh A Zabetian P Sarbakhsh D Khalili WP James F Azizi, Int J Obes (Lond) 2009 33 1437 1445 10.1038/ijo.2009.180
28. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo DW Jones BJ Materson S Oparil JT Wright EJ Roccella, Jama 2003 289 2560 2571 10.1001/jama.289.19. 2560 12748199
29. Follow-up report on the diagnosis of diabetes mellitus. S Genuth KG Alberti P Bennett J Buse R Defronzo R Kahn J Kitzmiller WC Knowler H Lebovitz A Lernmark, et al. Diabetes Care 2003 26 3160 3167 14578255 (Pubitemid 37339514)
30. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res 1998 6 Suppl 2 51S 209S 9813653
31. Standards of Medical Care in Diabetes - 2010. American Diabetes Association, Diabetes Care 2010 33 11 S61 20042772
32. A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study. M Bozorgmanesh F Hadaegh S Ghaffari H Harati F Azizi, Eur J Public Health 2010
33. DW Hosmer S Lemeshow, Applied logistic regression Wiley-Interscience 2000
34. FE Harrell, Regression modeling strategies Springer New York 2001
35. Weight change and risk of developing type 2 diabetes. Y Oguma HD Sesso RS Paffenbarger IM Lee, Obes Res 2005 13 945 951 10.1038/oby.2005.109 15919849
36. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. AJ Hanley AJ Karter K Williams A Festa RB D'Agostino LE Wagenknecht SM Haffner, Circulation 2005 112 3713 3721 10.1161/CIRCULATIONAHA.105.559633 16344402 (Pubitemid 43739511)
37. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). E Ferrannini A Natali P Bell P Cavallo-Perin N Lalic G Mingrone, J Clin Invest 1997 100 1166 1173 10.1172/JCI119628 9303923
38. Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know? AD Karelis DH St-Pierre F Conus R Rabasa-Lhoret ET Poehlman, J Clin Endocrinol Metab 2004 89 2569 2575 10.1210/jc.2004-0165 15181025 (Pubitemid 38766333)
39. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. J Arnlov E Ingelsson J Sundstrom L Lind, Circulation 121 230 236
40. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. MR Bozorgmanesh F Hadaegh M Padyab Y Mehrabi F Azizi, Ann Nutr Metab 2008 53 13 22 10.1159/000152869 18772585
41. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. F Hosseinpanah M Barzin PS Eskandary P Mirmiran F Azizi, BMC Public Health 2009 9 426 10.1186/1471-2458-9-426 19930614